This suggests the presence of CAMLs appear to be more sensitive than standard cancer biomarkers and future studies must be done to confirm the usefulness of CAMLs as a diagnostic biomarker in comparison to CTCs, CA19-9, and CEA. Here, CEACAM5 is linked to cancer.